Rare tumors of the colon and rectum: a national review
- 462 Downloads
Most literature available on rare colorectal cancer (CRC) is from case series reports. This population-based evaluation is the first comprehensive look at four rare histologic types of CRC, allowing comparisons with the more common adenocarcinoma for clinical and pathological features and survival rates.
Materials and ethods
All patients diagnosed with carcinoid (n=2,565), malignant lymphoma (n=955), non-carcinoid neuroendocrine (n=455), squamous cell (n=437), and adenocarcinoma (n=164,638) in SEER cancer database (1991–2000) were analyzed. Evaluation of age-adjusted incidence rate, stage at presentation, and 5-year relative survival were determined for each histologic subtype.
All rare histologic subtypes had younger mean age than adenocarcinomas (70 years; p<0.05). Lymphoma was more common in males (65.1%; P<0.01). Incidence rates in 2000 per million were: carcinoid 10.6, lymphoma 3.5, neuroendocrine 2.0, squamous 1.9, and adenocarcinoma 496.3. The annual percent change in incidence for each rare tumor increased significantly during the 10 years (range: 3.1–9.4%, p<0.05), except squamous cell carcinoma (5.9%, p>0.05). Squamous (93.4%) and carcinoid (73.7%) tumors occurred more often in the rectum; lymphoma (79.0%), neuroendocrine (70.8%), and adenocarcinoma (70.1%) occurred more often in the colon (P<0.01). Carcinoids presented at earlier stage (localized/regional, 90.5%) more often than adenocarcinoma (80.6%; p<0.01), but squamous cell (82.1%; p=0.50), lymphoma(70.6%; p<0.01), and neuroendocrine (37.8%; p<0.01) presented at earlier stage similarly or less often than adenocarcinoma. Relative 5-year survival rate was highest for carcinoid (91.3%), and lowest for neuroendocrine tumors (21.4%).
This study provides the first population-based analysis of the epidemiology, tumor characteristics, and survival rates for rare CRC.
KeywordsColorectal SEER Carcinoid Lymphoma Rare tumor
This study was funded in part by a grant from the American Society of Colon and Rectal Surgeons (ASCRS) Research Foundation.
- 1.American Cancer Society (2004) Cancer facts and figures 2004. The American Cancer Society. No 5008.04. Surveillance Research, New YorkGoogle Scholar
- 2.Gloria Niehans: Neoplasms of the large and small intestine. Available at: http://www.lamp.med.umn.edu
- 4.Human colorectal cancer. The Mouse Models of Human Cancers Consortium (MMHCC) cancer models database on the EMICE website provided by National Cancer Institute (NCI); Available at: http://emice.nci.nih.gov/emice
- 8.Koch P, del Valle F, Berdel WE et al (2001) Primary gastrointestinal non-Hodgkin’s lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma—results of the prospective GermanMulticenter Study GIT NHL 01/92. J Clin Oncol 19:3874–3883PubMedGoogle Scholar
- 10.Surveillance Epidemiology and End Results (SEER) Program Public-Use Data (1973–1999), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2002, based on the November 2001 submission. Available at: http://www.seer.cancer.gov/about
- 11.Moore DS, McCabe GP (1998) Introduction to the practice of statistics. W.H. Freeman and Company, New YorkGoogle Scholar
- 27.North American Association of Central Cancer Registries. Available at: http://www.naaccr.org
- 28.Virnig BA, Warren JL, Cooper GS et al (2002) Studying radiation therapy using SEER-Medicare-linked data. Med Care 40(8 Suppl):IV49–IV54Google Scholar